These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 9647302)
1. Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism. Lehtovirta M; Kuikka J; Helisalmi S; Hartikainen P; Mannermaa A; Ryynänen M; Riekkinen PSr ; Soininen H J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):742-6. PubMed ID: 9647302 [TBL] [Abstract][Full Text] [Related]
2. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. Lehtovirta M; Soininen H; Laakso MP; Partanen K; Helisalmi S; Mannermaa A; Ryynänen M; Kuikka J; Hartikainen P; Riekkinen PJ J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):644-9. PubMed ID: 8648331 [TBL] [Abstract][Full Text] [Related]
3. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow. Høgh P; Knudsen GM; Kjaer KH; Jørgensen OS; Paulson OB; Waldemar G J Geriatr Psychiatry Neurol; 2001; 14(1):42-51. PubMed ID: 11281316 [TBL] [Abstract][Full Text] [Related]
4. A longitudinal quantitative EEG study of Alzheimer's disease: relation to apolipoprotein E polymorphism. Lehtovirta M; Partanen J; Könönen M; Hiltunen J; Helisalmi S; Hartikainen P; Riekkinen P; Soininen H Dement Geriatr Cogn Disord; 2000; 11(1):29-35. PubMed ID: 10629359 [TBL] [Abstract][Full Text] [Related]
5. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging. Jobst KA; Barnetson LP; Shepstone BJ Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study. Brown DR; Hunter R; Wyper DJ; Patterson J; Kelly RC; Montaldi D; McCullouch J J Psychiatr Res; 1996; 30(2):109-26. PubMed ID: 8816305 [TBL] [Abstract][Full Text] [Related]
7. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors. Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621 [TBL] [Abstract][Full Text] [Related]
8. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease. Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study. Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175 [TBL] [Abstract][Full Text] [Related]
10. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease. Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226 [TBL] [Abstract][Full Text] [Related]
11. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799 [TBL] [Abstract][Full Text] [Related]
12. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548 [TBL] [Abstract][Full Text] [Related]
13. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. O'Brien JT; Eagger S; Syed GM; Sahakian BJ; Levy R J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1182-7. PubMed ID: 1479398 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E genotype and early Alzheimer's disease: a longitudinal SPECT study. Sakamoto S; Matsuda H; Asada T; Ohnishi T; Nakano S; Kanetaka H; Takasaki M J Neuroimaging; 2003 Apr; 13(2):113-23. PubMed ID: 12722493 [TBL] [Abstract][Full Text] [Related]
15. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. Defebvre LJ; Leduc V; Duhamel A; Lecouffe P; Pasquier F; Lamy-Lhullier C; Steinling M; Destée A J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Ji Y; Urakami K; Adachi Y; Maeda M; Isoe K; Nakashima K Dement Geriatr Cogn Disord; 1998; 9(5):243-5. PubMed ID: 9701675 [TBL] [Abstract][Full Text] [Related]
18. Anterior choroidal artery infarction presenting as a progressive cognitive deficit. Sarangi S; San Pedro EC; Mountz JM Clin Nucl Med; 2000 Mar; 25(3):187-90. PubMed ID: 10698414 [TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease: scintigraphic appearance of Tc-99m HMPAO brain spect. Lee BF; Liu CK; Tai CT; Chiu NT; Liu GC; Yu HS; Pai MC Kaohsiung J Med Sci; 2001 Aug; 17(8):394-400. PubMed ID: 11715838 [TBL] [Abstract][Full Text] [Related]